Comments on:

Lilly 2013 profit forecast tops expectations

Back to the article » |
INDIANAPOLIS (AP) — Eli Lilly and Co. unveiled a better-than-expected 2013 earnings forecast Friday, in part because the pharmaceutical company expects growth from several established drugs to help make up for revenue lost to generic competition. The Indianapolis drug developer saw sales for its all-time best-selling drug, the antipsychotics Zyprexa, crater in 2012 after it lost U.S. patent...

To learn more about commenting on WashingtonExaminer.com and our community guidelines, please see our comments FAQ.